JOHNS HOPKINS UNIVERSITY
Auditory circuit organization following gene therapy for congenital deafness
Auditory circuit organization following gene therapy for congenital deafness is a funding opportunity from JOHNS HOPKINS UNIVERSITY, up to 582552, closing July 31, 2028.
Jul 31, 2028
(731d left)Overview
PROJECT SUMMARY This project seeks to understand the critical role of otoferlin in auditory circuit development and how gene therapy can be optimized to restore hearing in patients with congenital deafness caused by otoferlin variants. Otoferlin is a key calcium sensor that facilitates synaptic vesicle fusion and…